Abstract
Between January 1999 and June 2002, 646 invasive isolates of Streptococcus pneumoniae were collected in Ireland. MICs of penicillin, ciprofloxacin, cefotaxime, moxifloxacin and linezolid were determined by Etest methodology. Eighty-seven (13.5%) isolates showed intermediate resistance to penicillin, while seven (1.1%) showed high-level resistance. Eighty-seven (13.5%) isolates were resistant to erythromycin, but all isolates were susceptible to cefotaxime, moxifloxacin and linezolid. The prevalence of pneumococcal isolates non-susceptible to penicillin in Ireland is worryingly high, but currently there are alternative agents available to treat invasive infection. © 2004 Copyright by the European Society of Clinical Microbiology and Infectious Diseases.
Author supplied keywords
Cite
CITATION STYLE
Clarke, P., Murchan, S., Smyth, E. G., & Humphreys, H. (2004). Antimicrobial susceptibility of invasive isolates of Streptococcus pneumoniae in Ireland. Clinical Microbiology and Infection, 10(7), 657–659. https://doi.org/10.1111/j.1469-0691.2004.00894.x
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.